Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology and Hepatology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Ophthalmology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
ASH 2024 Annual Meeting 2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Podcast | Sexual health in older age

Dr Holly Thomas helps us unpack the needlessly taboo subject of sex and sexual health in women of older age.

Listen now
ADVANCED SEARCH
Log in
Top
European Radiology

05-03-2025 | Lung Cancer | Computed Tomography

Preliminary reports of lung cancer screening with low-dose computed tomography: a nationwide performance on the Korean population in 2019–2020

Authors: Horim A. Hwang, Dong Jun Kim, Nan-He Yoon, Jae Kwan Jun, Mina Suh, Sunhwa Lee, Seongju Kim, Seung Eun Jung, Hooyeon Lee

Published in: European Radiology

Login to get access

Abstract

Background

Korea introduced its National Lung Cancer Screening Program (NLCSP) with low-dose computed tomography (LDCT) in 2019. However, there are few published results of lung cancer screening at national level. We investigated the performance of LDCT for lung cancer screening and suggested recommendations for improving a nationwide population-based program.

Materials and methods

This study was a nationwide, population-based cross-sectional study. We analyzed the Korean National Health Insurance Big Data Base, which included lung cancer-related screening information between 2019 and 2020, was analyzed. Performance indicators were the number of examinations, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), overexposure, and suspected lung cancer (LCA). The performance indicators were stratified according to screening year, sex, age group, and region.

Results

A total of 149,936 examinations were done in 2019–2020. Most participants were men (98.3%) or were aged 54–59 or 60–64 (35.2% and 38.2%). The sensitivity, specificity, PPV, NPV, overexposure, and suspected LCA were 82.9%, 91.9%, 6.4%, 99.9%, 2.7%, and 4.0%, respectively. Women showed lower sensitivity than men. In 2020, there was a substantial increase in PPV (11.0%), and a substantial decrease in overexposure (47.7%) and suspected LCA (16.9%) compared to 2019. At regional level, there was a large variance in sensitivity, PPV, overexposure, and suspected LCA.

Conclusions

Korea’s NLCSP successfully demonstrated validity and reliability at national level. Sexual, and regional differences should be addressed to improve NLCSP.

Key Points

Question How has biennial low-dose CT (LDCT) lung cancer screening performed in Korea for individuals aged 54–74 years with a smoking history of ≥ 30 pack-years?
Findings The sensitivity, specificity, and positive predictive value were 82.9%, 91.9%, and 6.4%.
Clinical relevance Korea’s program demonstrated a similar level of validity and reliability of previous lung cancer screening studies at national level. It facilitated early diagnosis of lung cancer for all the relevant Korean population and laid the foundation for long-term cancer screening.
Literature
1.
Corrales L, Rosell R, Cardona AF, Martin C, Zatarain-Barron ZL, Arrieta O (2020) Lung cancer in never smokers: the role of different risk factors other than tobacco smoking. Crit Rev Oncol Hematol 148:102895CrossRefPubMed
2.
3.
4.
Kim W, Lee SC, Lee WR, Chun S (2023) The effect of the introduction of the National Lung Cancer Screening Program on short-term mortality in Korea. Lung Cancer 186:107412CrossRefPubMed
5.
New York Early Lung Cancer Action Project Investigators (2007) CT Screening for lung cancer: diagnoses resulting from the New York Early Lung Cancer Action Project. Radiology 243:239–249CrossRef
6.
Gierada DS, Black WC, Chiles C, Pinsky PF, Yankelevitz DF (2020) Low-dose CT screening for lung cancer: evidence from 2 decades of study. Radiol Imaging Cancer 2:e190058CrossRefPubMedPubMedCentral
7.
de Koning HJ, van der Aalst CM, de Jong PA et al (2020) Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med 382:503–513CrossRefPubMed
8.
National Lung Screening Trial Research Team (2019) Lung cancer incidence and mortality with extended follow-up in the National Lung Screening Trial. J Thorac Oncol 14:1732–1742CrossRef
9.
National Lung Screening Trial Research Team, Aberle DR, Adams AM et al (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395–409CrossRef
10.
11.
Wait S, Alvarez-Rosete A, Osama T et al (2022) Implementing lung cancer screening in Europe: taking a systems approach. JTO Clin Res Rep 3:100329PubMedPubMedCentral
12.
Pham D, Bhandari S, Pinkston C, Oechsli M, Kloecker G (2020) Lung cancer screening registry reveals low-dose CT screening remains heavily underutilized. Clin Lung Cancer 21:e206–e211CrossRefPubMed
13.
14.
Reck M, Dettmer S, Kauczor HU, Kaaks R, Reinmuth N, Vogel-Claussen J (2023) Lung cancer screening with low-dose computed tomography. Dtsch Arztebl Int 120:387–392PubMedPubMedCentral
15.
Adamek M, Biernat W, Chorostowska-Wynimko J et al (2020) Lung cancer in Poland. J Thorac Oncol 15:1271–1276CrossRefPubMed
16.
Kerpel-Fronius A, Megyesfalvi Z, Markoczy Z et al (2024) HUNCHEST-II contributes to a shift to earlier-stage lung cancer detection: final results of a nationwide screening program. Eur Radiol 34:3462–3470CrossRefPubMed
17.
18.
Kang MJ, Jung KW, Bang SH et al (2023) Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2020. Cancer Res Treat 55:385–399CrossRefPubMedPubMedCentral
19.
Lee J, Kim Y, Kim HY et al (2021) Feasibility of implementing a national lung cancer screening program: interim results from the Korean Lung Cancer Screening Project (K-LUCAS). Transl Lung Cancer Res 10:723–736CrossRefPubMedPubMedCentral
20.
21.
22.
23.
24.
Shin DW, Cho J, Park JH, Cho B (2022) National General Health Screening Program in Korea: history, current status, and future direction. Precis Future Med 6:9–31CrossRef
25.
Mendoza DP, Petranovic M, Som A et al (2022) Lung-RADS Category 3 and 4 nodules on lung cancer screening in clinical practice. AJR Am J Roentgenol 219:55–65CrossRefPubMed
26.
Kim HY (2019) National lung cancer screening in Korea: introduction and imaging quality control. J Korean Soc Radiol 80:826–836
27.
Jonas DE, Reuland DS, Reddy SM et al (2021) Screening for lung cancer with low-dose computed tomography: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 325:971–987CrossRefPubMed
28.
29.
Kerpel-Fronius A, Monostori Z, Kovacs G et al (2022) Nationwide lung cancer screening with low-dose computed tomography: implementation and first results of the HUNCHEST screening program. Eur Radiol 32:4457–4467CrossRefPubMed
30.
Kim H, Kim HY, Goo JM, Kim Y (2020) Lung cancer CT screening and Lung-RADS in a tuberculosis-endemic country: the Korean Lung Cancer Screening Project (K-LUCAS). Radiology 296:181–188CrossRefPubMed
31.
32.
Yoo KJ, Lee Y, Lee S et al (2023) The road to recovery: impact of COVID-19 on healthcare utilization in South Korea in 2016–2022 using an interrupted time-series analysis. Lancet Reg Health West Pac 41:100904PubMedPubMedCentral
33.
34.
Higgins ST, Kurti AN, Redner R et al (2015) A literature review on prevalence of gender differences and intersections with other vulnerabilities to tobacco use in the United States, 2004–2014. Prev Med 80:89–100CrossRefPubMedPubMedCentral
35.
Lohse T, Rohrmann S, Bopp M, Faeh D (2016) Heavy smoking is more strongly associated with general unhealthy lifestyle than obesity and underweight. PLoS One 11:e0148563CrossRefPubMedPubMedCentral
36.
37.
38.
Chang GC, Chiu CH, Yu CJ et al (2024) Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study. Lancet Respir Med 12:141–152CrossRefPubMed
39.
40.
Thandra KC, Barsouk A, Saginala K, Aluru JS, Barsouk A (2021) Epidemiology of lung cancer. Contemp Oncol 25:45–52
41.
Song HN, Go SI, Lee WS et al (2016) Population-based regional cancer incidence in Korea: comparison between urban and rural areas. Cancer Res Treat 48:789–797CrossRefPubMed
42.
Metadata
Title
Preliminary reports of lung cancer screening with low-dose computed tomography: a nationwide performance on the Korean population in 2019–2020
Authors
Horim A. Hwang
Dong Jun Kim
Nan-He Yoon
Jae Kwan Jun
Mina Suh
Sunhwa Lee
Seongju Kim
Seung Eun Jung
Hooyeon Lee
Publication date
05-03-2025
Publisher
Springer Berlin Heidelberg
Published in
European Radiology
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-025-11461-z